Latest Breaking News On - Julie rathbun - Page 13 : vimarsana.com
Neoleukin Therapeutics Announces First Quarter 2021 Financial Results and Corporate Update
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Athira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal Repair Pathway
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Neoleukin Therapeutics, Inc (NLTX) Q4 2020 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Presage Sets the Stage for Commercial Expansion with Closing of $13M Financing and Execution of New Phase 0 Trial Agreements with Merck and Maverick Therapeutics
- Funds to Support Expansion of CIVO® Technology Platform
- New Collaborations to Utilize CIVO for Phase 0 Studies
News provided by
Share this article
Share this article
SEATTLE, March 2, 2021 /PRNewswire/ Presage Biosciences, Inc., a biotechnology company pioneering a new cancer drug development approach using its Comparative
In Vivo Oncology (CIVO®) intratumoral microdosing platform, today announced the closing of a $13 million financing and commencement of new research collaborations with Merck, known as MSD outside of the United States and Canada, and Maverick Therapeutics.